Bora CDMO Bora CDMO

X

Find Radio Compass News for Dalcetrapib

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

https://www.globenewswire.com/news-release/2021/01/11/2156093/0/en/DalCor-Announces-Launch-of-Dalcetrapib-Clinical-Trial-for-COVID-19.html

GLOBENEWSWIRE
11 Jan 2021

https://endpts.com/dalcor-taps-new-ceo-fouzia-laghrissi-thode-as-pivotal-phiii-looms-kelly-martin-settles-in-at-novan-edward-stewart-takes-over-commense/

Amber Tong ENDPTS
14 Apr 2018

http://www.prnewswire.com/news-releases/dalcor-randomizes-first-patient-in-the-dalgene-phase-3-cardiovascular-outcomes-trial-300256440.html

PR NEWS WIRE
27 Apr 2016

http://www.mmm-online.com/therapeutic-focus/new-cardiovascular-drugs-raise-concerns-about-pricing-efficacy/article/460650/

MMM
21 Dec 2015

http://www.pmlive.com/pharma_news/merck_seeks_oasis_in_cetp_inhibitor_desert_868680

Phil Taylor PHARMATIMES
18 Nov 2015

http://www.dailymail.co.uk/wires/reuters/article-3116808/Canadians-hope-250-mln-trial-revive-failed-Roche-heart-drug.html

DAILY MAIL
11 Jun 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY